Lauren Strazzula is a Dermatology physician affiliated with South Shore Hospital. OpenAlex indexes 20 publications with 544 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Scobee Cir Ste 3
Plymouth, MA 023604887
Telephone
508-747-0711Registry record last updated 9 Nov 2018.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202520 payments
- Janssen Biotech, Inc.Program year202512 payments
- ABBVIE INC.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
89.7%Porphyrin Precursor88.3%Aminolevulinic acid hcl100%Part B, office-administered≥22 patientsNucleoside Metabolic Inhibitor1%Fluorouracil100%Part D≥48 patients+ 1 more class in this area
Anti-infectives
4.5%Azole Antifungal2.5%Ketoconazole100%Part D≥89 patientsTetracycline-class Drug0.7%Doxycycline Hyclate100%Part D≥18 patients+ 3 more classes in this area
Sensory organs
2.6%Corticosteroid2.6%Hydrocortisone43%Clobetasol Propionate32%Betamethasone Dipropionate25%Part D≥46 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- LB779 Comparison of outcomes for intravenous and intralesional administration of sodium thiosulfate for treatment of Calciphylaxis
Journal of Investigative Dermatology
2021 - LB780 Risk factors predicting Cellulitis diagnosis in a prospective cohort undergoing dermatology consultation in the Emergency Department
Journal of Investigative Dermatology
2021 - Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate
Journal of the American Academy of Dermatology
2020 - Patient preference for cellulitis treatment: At-home care is preferred to hospital-based treatment
Journal of the American Academy of Dermatology
2020 - Reply to: Comment on “Patient preference for cellulitis treatment: At-home care is preferred to hospital-based treatment”
Journal of the American Academy of Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”